Skip to main content
Premium Trial:

Request an Annual Quote

Collaboration to Develop Knowledgebase of Pathways for Prostate Cancer

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ariadne, Cellecta, and the Roswell Park Cancer Institute today announced they will collaborate to develop a knowledgebase of prostate-specific pathway models.

Under the agreement, Cellecta will use its Decipher functional genomics technology to screen for a panel of prostate cancer cell lines to identify genes that are essential for cancer cell viability. From that, Ariadne will use available 'omics data to identify the pathways involved and to "build mechanistic models in support of the genes identified from the siRNA targets in the screen," the Rockville, Md., company said in a statement.

Roswell will contribute its expertise in prostate cancer biology and clinical applications.

Together the partners hope to bring about "a better understanding of the mechanisms of prostate cancer that result in novel targets and biomarkers," Ilya Mazo, CEO of Ariadne, said.

The project is partially funded by a National Cancer Institute SBIR Phase 1 grant. According to a spokeswoman from Ariadne, the two-year $400,000 grant covers all but $100,000 for the project, which Ariadne will pay.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.